slides · global inventory
11 Golden Circle
Loop collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 13,983
Current window 8,011-8,040
Pages 467
Rows per page 30
Loop
8,011-8,040 of 13,983
09
AN2 Therapeutics | IPO Presentation Deck | 27 slidesAN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
10
AN2 Therapeutics | IPO Presentation Deck | 27 slidesAN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
11
Uses a Venn/concentric circle diagram to illustrate market segmentation.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
12
The slide uses a process flow to show the progression from treatment-naïve to refractory patients.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
13
Includes boxed warning information for a competitor/reference drug.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
14
Scientific diagram showing molecular binding interaction.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
15
MIC = Minimum Inhibitory Concentration. Data shows Epetraborole has lower MIC values compared to standard treatments.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
16
The chart highlights statistical significance between EBO doses and the CLR control.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
17
EBO = epetraborole, SoC = standard of care (clarithromycin, ethambutol, rifabutin).AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
18
Includes a timeline diagram of the study design and key clinical findings.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
19
The slide highlights the drug's targeted delivery to the site of infection (alveolar macrophages).AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
20
The slide outlines a seamless trial design with specific patient counts and milestones.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
21
Uses a concentric circle diagram to represent market segments and a map to show geographic reach.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
22
The table uses checkmarks and X marks to highlight competitive advantages of EBO.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
23
QIDP = Qualified Infectious Disease Product DesignationAN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
24
Includes a timeline of clinical trials and a list of key investors.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
25
The slide highlights a focus on melioidosis and lists key research and funding partners.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
26
The slide uses a split-layout with a company mission statement on the left and product details on the right.AN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
27
AN2 Therapeutics | IPO Presentation Deck | 27 slidesAN2 Therapeutics | IPO Presentation Deck | 27 slides · AN2 Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit
10
The slide uses a biological pathway diagram to illustrate the mechanism of action.Apexigen | SPAC Presentation Deck | 28 slides · Apexigen
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
11
Apexigen | SPAC Presentation Deck | 28 slidesApexigen | SPAC Presentation Deck | 28 slides · Apexigen
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
09
The slide uses a four-column layout to categorize strategic growth drivers.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Beat · Key TakeawaysLoop · Golden Circle1 hit
10
The slide uses a table to categorize pipeline progress by regulatory status and geography.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Beat · KPI OverviewLoop · Golden Circle1 hit
11
Includes footnotes explaining CER (constant exchange rates), R&D, SG&A, and pp (percentage points).AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Beat · KPI OverviewLoop · Golden Circle1 hit
12
Includes footnotes regarding CER (constant exchange rates), R&D, SG&A, and percentage points.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Beat · KPI OverviewLoop · Golden Circle1 hit
13
The slide uses a four-column layout to present financial projections and qualitative business drivers.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Beat · KPI OverviewLoop · Golden Circle1 hit
14
AstraZeneca | Investor Presentation Deck | 53 slidesAstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Beat · Section DividerLoop · Golden Circle1 hit
15
The waterfall chart includes a specific callout for acquisition-related debt.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Loop · Golden Circle1 hit
16
AstraZeneca | Investor Presentation Deck | 53 slidesAstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Loop · Golden Circle1 hit
17
Includes regional breakdown (US, Europe, ERoW, EM) and specific clinical/market drivers.AstraZeneca | Investor Presentation Deck | 53 slides · AstraZeneca
Conference presentation Investor relations Loop · Golden Circle1 hit